P/E ratio for West Pharmaceutical (WST)

P/E ratio history for West Pharmaceutical from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Becton Dickinson BDX	44.5	-1.61%	🇺🇸 USA
Antares Pharma ATRS	16.4	-63.64%	🇺🇸 USA
ICU Medical ICUI	-83.3	-284.27%	🇺🇸 USA
Stryker Corporation SYK	57.4	27.00%	🇺🇸 USA
Baxter BAX	6.40	-85.84%	🇺🇸 USA
Teleflex TFX	21.0	-53.56%	🇺🇸 USA
Medtronic MDT	33.6	-25.67%	🇮🇪 Ireland
Johnson & Johnson JNJ	10.7	-76.27%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.